Warning lights
Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.
-
Two loss years in a row NBB
Negative result in 2023 and 2024.
-
Busy address KBO
60 other companies have their registered office at the same address; threshold 10.
-
Not on Peppol Peppol
Not registered in the Peppol network, mandatory for VAT-liable companies since 1 January 2026.
Financials
Financial year 2024
THEODORUS IV from Anderlecht, company number BE0707902931, closed financial year 2024 with a result of € -2.4 million after tax. For that financial year THEODORUS IV recorded a gross margin of € -717,536 and equity of € 12 million. Compared with financial year 2023, the result moved from € -2.3 million to € -2.4 million. The company made a loss. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on October 14, 2025.
€ 12 million
▲ 34% vs 2023
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ -2.4 million
▼ 6 % more loss than in 2023
Profit after tax over the fiscal year.
€ 323,713
▼ 77% vs 2023
Cash and bank balances on the last day of the fiscal year.
Loss, nothing to pay out
Reserves fell to € -8.2 million.
Debts at end 2024
None
No bank loans on the last day of the fiscal year.
€ 8,016
▲ 52% vs 2023
Supplier invoices still open on the last day of the fiscal year.
Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →
| 2021 | 2022 | 2023 | 2024 | Change 2023 → 2024 | |
|---|---|---|---|---|---|
| Gross margin | € -835,470 | € -858,348 | € -938,471 | € -717,536 | ▲ € 220,935 |
| Profit after taxes | € -872,230 | € -1,017,180 | € -2,279,292 | € -2,408,224 | ▼ € 128,931 |
| Equity | € 9,012,742 | € 11,283,062 | € 9,003,770 | € 12,026,945 | ▲ 34% |
| Total debts | € 15,988 | € 34,603 | € 218,990 | € 61,539 | ▼ 72% |
| Cash | € 3,903,770 | € 2,890,603 | € 1,413,958 | € 323,713 | ▼ 77% |
| Retained profit | € -2,493,508 | € -3,510,688 | € -5,789,980 | € -8,198,204 | ▼ € 2.4 million |
| Balance sheet total | € 9,028,730 | € 11,317,665 | € 9,222,760 | € 12,088,484 | ▲ 31% |
Key figures of THEODORUS IV, fiscal years 2021 to 2024, from the annual accounts filed with the National Bank of Belgium.The annual account for fiscal year 2025 has not been filed yet; it was expected before 31 July 2026.
What happened to THEODORUS IV?
What happened at THEODORUS IV in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- Finadvize SRL stepped down as director. NBB
- Finance & Invest.brussels stepped down as director. NBB
- Université Livre de Bruxelles stepped down as director. NBB
- Square L SA stepped down as director. NBB
- 50° North Ventures Sa stepped down as director. NBB
- Société Fédérale de Participations et d'Investissement SA stepped down as director. NBB
- BNP Paribas Fortis Private Equity Management SA stepped down as director. NBB
- Alexandre Franco stepped down as director. NBB
In short
From € 872,230 loss in 2021 to € 2.4 million loss in 2024.
A new publication or filing at THEODORUS IV? We notify you, reason included.
Follow THEODORUS IVDatabakkes Pro
Know what changes at your customers, suppliers and competitors. Without reading an annual account.
- Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
- We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
- In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.
Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.
De Lijn 8 June 2026 New annual account 2025
filed on 8 June 2026
What was left
€ 20 k ▼ 91%
Money in the bank
€ 178 k ▼ 98%
Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit
Management
The stake of V.D.B. FACULTY, finance&invest.brussels comes from that shareholder’s own annual accounts; small companies do not report their shareholders themselves.
THEODORUS IVThe shares are held by Société Fédérale de Participations et d'Investissements (30.4%), Sambrinvest Spin-Off/Spin-Out SA (15.2%), V.D.B. FACULTY (25%) and finance&invest.brussels (6.1%). It owns 60% of GEPECERON (ouverture faillite), 31.6% of INHATARGET THERAPEUTICS, 29.7% of KAPCARE, 19.7% of NEUVASQ BIOTECHNOLOGIES and 18.9% of NEOMABS BIOTECHNOLOGIES INC itself.
Directors
According to the 2024 annual accounts
since 2024 · until 2030
Director · represented by Barbara Roose
Also active at: BRUXELLES INFRASTRUCTURE FINANCE - BRUSSEL INFRASTUCTUUR FINANCIERING, BRUSERVICES, S.F.A.R., MAISON DE LA RADIO FLAGEY, BE ANGELS, THEODORUS III, INNOVATION FUND, SEEDER FUND +14 more
since 2024 · until 2030
Chairman of the board · represented by Daniele Carati
Also active at: HUmani, La Fonderie, TECHNOFUTUR TIC, Brussels South Charleroi BioPark Dev, UNIVERSITE OUVERTE DE LA FEDERATION WALLONIE-BRUXELLES, EUROMETROPOLITAN E-CAMPUS, BIOWIN, WAGRALIM
since 2024 · until 2030
Director · represented by Claude Jottrand
since 2024 · until 2030
Managing director · represented by André Ostachkov
Also active at: EEBIC, BE ANGELS, Brussels South Charleroi BioPark Dev, THEODORUS III, THEODIRIS, ALLERINVEST, KABANDY, SEEDER FUND +13 more
since 2024 · until 2030
Société Fédérale de Participations et d'Investissement SA
Director · represented by Matthieu De Posch
Also active at: Aviapartner Belgium, Société Anonyme Belge de Constructions Aéronautiques, Société Nationale de Construction Aérospatiale, COMETSAMBRE, ASCO INDUSTRIES, ZEPHYR - FIN, Sabena Aerospace Engineering, reMYND +57 more
since 2024 · until 2030
BNP Paribas Fortis Private Equity Management SA
Director · represented by Patricia Terryn
Also active at: Finex, HET ANKER, A.M.B., Haco, PCSI, QUALITY ASSISTANCE, Stûv, GEMMA FRISIUS-FONDS KU LEUVEN +15 more
since 2024 · until 2030
Alexandre Franco
Director
since 2024 · until 2030
Sambrinvest Spin-Off/Spin-Out SA
Director · represented by Helena Pozios
Also active at: BE ANGELS, Brussels South Charleroi BioPark Dev, 50°NORTH VENTURES, THEODORUS III, EMAsphere, AQUILON PHARMACEUTICALS, APIQUIET, BigCaptain +25 more
since 2024 · until 2030
Director · represented by Muriel De Lathouwer
Also active at: Centre d'accompagnement de projets innovants, Brussels South Charleroi BioPark Dev, 50°NORTH VENTURES, THEODORUS III, Pré Seed Fund, E-HEALTH VENTURE, Advanced Engineering Accelerator, Boost Engineering Pre-Seed Fund
since 2024 · until 2030
Shareholders
Participations
31.6%
29.7%
19.7%
NEOMABS BIOTECHNOLOGIES INC
18.9%
Establishments
Establishment units
Physical locations of this company
Researchdreef 12
1070 Anderlecht
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 60 companies are registered at this address.
All companies at this address →Vereniging van Frabrikanten en Invoerders van wetenschappelijke Medische en Controleapparaten
€ 678,657 revenue · 2025
CYRILLUS BENELUX
€ 1.9 million revenue · 2025
BATICOOL
€ 336,834 gross margin · 2024
EEBIC same network
€ 669,567 gross margin · 2025
TRIANGLE SOLUTIONS RH
€ 21.1 million revenue · 2024
+55 more
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 0707.902.931
- VAT number
- BE 0707.902.931
- Registered office
- Researchdreef 12, 1070 Anderlecht
- Names & denominations
- THEODORUS IV
- Enterprise type
- Rechtspersoon
- Legal form
- Public limited company
- Legal situation
- Normale toestand
- Start date
- 8 October 2018
- Peppol
- Not registered